In vitro and in vivo evidence discourages routine testing and reporting of piperacillin/tazobactam susceptibility of Elizabethkingia species.
J Antimicrob Chemother
; 79(1): 200-202, 2024 Jan 03.
Article
in En
| MEDLINE
| ID: mdl-37850648
Full text:
1
Database:
MEDLINE
Main subject:
Flavobacteriaceae Infections
Limits:
Humans
Language:
En
Journal:
J Antimicrob Chemother
Year:
2024
Type:
Article
Affiliation country:
Taiwan